Mida tähendab "Tühjenda"?
Loom ei kanna mutatsiooni. See ei arenda haigust ja ei anna seda edasi.
Kass Alfa-mannosidoos (AlphaMan)
Alpha Mannosidosis (AlphaMan) is a rare genetic disorder affecting cats, caused by a deficiency of the enzyme alpha-mannosidase. This DNA test helps identify carriers and affected cats, enabling responsible breeding decisions to prevent the spread of the disease. Early detection through the Alpha Mannosidosis DNA test is crucial for managing symptoms and improving feline health. By screening your cat, you contribute to reducing the incidence of AlphaMan in future generations. Trusted by veterinarians and breeders, this test provides accurate and reliable results. Ensure your cat’s well-being with the Alpha Mannosidosis DNA test today. Protect your feline companion from hereditary health risks with this essential genetic screening.
Lühend: AlphaMan
Analüüsitud mutatsioon: MAN2B1 c.1749_1752del
Pärand: Autosoomne retsessiivne
Akronüüm
AlphaMan
Täheldatud sagedus
Kliiniline raskusaste
Kliiniline klassifikatsioon
Ainevahetushaigused
Analüüsitud mutatsioon
MAN2B1 c.1749_1752del
p.(Q584Afs)
p.(Q584Afs)
Pärimisviis
Autosoomne retsessiivne
Testi kokkuvõte:
Alpha Mannosidosis (AlphaMan) is a rare genetic disorder in cats caused by a deficiency of the enzyme alpha-mannosidase. This leads to the accumulation of complex sugars in cells, resulting in progressive neurological and physical symptoms. A DNA test for AlphaMan helps identify carriers and affected cats, enabling responsible breeding decisions. Early detection through testing can improve management and care for affected cats. Genetic screening is essential to reduce the incidence of this debilitating condition in feline populations.
Saadaval pakendist: Basic
See DNA test on kaasas alates meie pakist Basic — ja on ka osa pakkidest Basic, Standard, Advanced, Complete.
Vaadake DNA testipakette →Valige pakk, mis sobib teie loomade aretus- või tervisestrateegiaga kõige paremini.
Understanding Alpha Mannosidosis in Cats
Alpha Mannosidosis (AlphaMan) is a rare genetic disorder that affects the metabolism of certain sugars in the body. It is caused by a deficiency in the enzyme alpha-mannosidase, which is responsible for breaking down mannose-containing oligosaccharides. When this enzyme is deficient or absent, these sugars accumulate in the body's cells, leading to a range of health issues.
Symptoms and Clinical Manifestations
Cats with Alpha Mannosidosis may exhibit a variety of clinical symptoms that can vary in severity. Common signs include neurological deficits, such as poor coordination, muscle weakness, and behavioral changes. Additionally, affected cats might experience growth delays, skeletal abnormalities, and impaired immune function. The onset of symptoms can occur at different ages, often leading to a progressive decline in health over time.
Diagnosis of Alpha Mannosidosis
Diagnosing Alpha Mannosidosis typically involves a combination of clinical evaluation and laboratory testing. A veterinarian will assess the cat's medical history and symptoms, followed by conducting biochemical tests to measure enzyme activity. Genetic testing through DNA analysis can confirm the presence of mutations in the gene responsible for encoding the alpha-mannosidase enzyme, providing a definitive diagnosis.
Juhtimis- ja ravivõimalused
Currently, there is no cure for Alpha Mannosidosis, and treatment is primarily supportive. Management strategies may include symptomatic care to improve the quality of life for affected cats. This can involve nutritional support, physical therapy, and regular veterinary check-ups to monitor the animal's condition. Research is ongoing to explore potential therapeutic options, including enzyme replacement therapy and gene therapy, which may offer hope for future treatments.
Geneetilise testimise tähtsus
Genetic testing for Alpha Mannosidosis is crucial for breeders and pet owners to identify carriers of the gene mutation and prevent the propagation of this disorder. By understanding the genetic status of their cats, responsible breeding practices can be implemented to reduce the risk of this condition in future generations. Additionally, early detection through DNA testing can help owners make informed decisions regarding the health management of their pets.
Testi jaoks tunnustatud tõug: Alfa-mannosidoos (AlphaMan)
- Persian
🧬 Interpretation of genotypes AlphaMan
Genotüüp
Olek
🟡 N/N
Mittekandja – riskivaba
🟡 N/AlphaMan
Vedaja – riskivaba
❌ AlphaMan/AlphaMan
Mõjutatud – ohus
KKK: tõlgenduse mõistmine
Kas "kandja" on tõsine?
Ei. Loom on üldiselt terve, kuid võib mutatsiooni omale edasi anda järglased.
Mis siis, kui loom on "mõjutatud"?
Sellel on kaks muteerunud koopiat. Sõltuvalt sellest on oodata kliinilisi tunnuseid haigus. Seda ei tohiks aretada.
Miks on meeste ja naiste vahel erinevusi?
Mõned haigused on sooga seotud, mistõttu nende väljendus varieerub sõltuvalt looma sugu.
Ennusta järglasi
N/N (mittekandja)
N/AlphaMan (Kandja)
AlphaMan/AlphaMan (Mõjutatud)
DNA-testi KKK
Mida see DNA test tuvastab?
This DNA test detects the mutation associated with Alpha Mannosidosis (AlphaMan) in order to identify clear, carrier, or at-risk animals.
Miks testida aretuslooma?
DNA testimine aitab kasvatajatel planeerida turvalisemaid paaritusi ja vähendada mutatsiooni järglastele edasikandumise ohtu.
Mis on selle testi pärimisviis?
Selle testi jaoks teatatud pärimisrežiim on autosoomne retsessiivne.
Millist mutatsiooni selles testis analüüsitakse?
This test analyses the mutation MAN2B1 c.1749_1752del.
Kas kandjaloom on tingimata mõjutatud?
Mitte tingimata. Tõlgendamine sõltub pärimismustrist ja sellest tulenevast genotüübist.
Viited
Berg T, Tollersrud O K, Walkley S U, Siegel D, Nilssen O. Purification of feline lysosomal alpha-mannosidase, determination of its cDNA sequence and identification of a mutation causing alpha-mannosidosis in Persian cats. Biochem J. 1997 Dec 15;328 ( Pt 3)(Pt 3):863-70. doi: 10.1042/bj3280863.